Hepatitis B virus surface antigen reactivity in the absence of antibodies to core antigen: An atypical serological pattern having diverse significance;Reactividad para antígeno de superficie del virus de la hepatitis B en ausencia de anticuerpos frente al antígeno de la cápside del virus de la hepatitis B: Un patrón serológico atípico de significado diverso

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 22, Issue 1, 2004, Pages 6-12

  Echevarría, José María ^a   León, Pilar ^a   Pozo, Francisco ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Acute hepatitis B; HBsAg; Hepatitis B virus; Hepatitis B virus type 2; Hepatitis B virus variants

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ACUTE DISEASE; ACUTE HEPATITIS B; ANTIBODY RESPONSE; ARTICLE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS B VIRUS TYPE 2; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; VIRUS DETECTION; VIRUS HEPATITIS;

EID: 12144289461     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13056685     Document Type: Article

References (29)

1. Chiaramonte M, Stroffolini T, Ngatchu T, Rapicetta M, Lantum D, Kaptue J, et al. Hepatitis B virus infection in Cameroon. A seroepidemiological survey in city school children. J Med Virol 1991;33:95-9.
2. Sastre A, Ariño V, Gutiérrez JL, León P, Echevarria JM. ¿Infección por VHB-2? Enferm Infecc Microbiol Clin 1991;9:581-2.
3. Benito R, Bernad JM, Pérez Calvo J, Rubio MC. Perfiles compatibles con infección por el VHB-2. Rev Esp Microbiol Clin 1992;7:510-1.
4. Santana OE, Francés A, Sierra A, Hernández J, Martín-Sánchez AM. Marcadores serológicos de hepatitis B: patrones atipicos detectados en el Hospital Insular de Gran Canaria. Rev Clin Esp 1995;195:674-7.
5. Buisson Y, Coursaget P, Bourdil C, Schill H, Joussemet M, Molinié C. Hepatitis B virus type 2 infection in France. Res Virol 1990;141:365-7.
6. Echevarría JM, León P, Domingo CJ, López JA, Echevarría JE, Contreras G, et al. Characterization of HBV2-like infections in Spain. J Med Virol 1991;33:240-7.
7. Ratnam S, Stead F, Head CB. False-positive results with third generation monoclonal hepatitis B surface antigen enzyme immunoassay. J Clin Microbiol 1989;27:2102-4.
8. c negativity. Hepatology 1989;9:102-4.
9. c-nonreactive blood donor: Variant virus or defective immune response? Hepatology 1992;16:24-30.
10. Bhat RA, Ulrich PP, Vyas GN. Molecular characterization of a new variant of hepatitis B virus in a persistently infected homosexual man. Hepatology 1990;11:271-6.
11. c. J Hepatol 1991;13:187-91.
12. sAg positive reactivity in man not due to hepatitis B virus. Lancet 1987;II:1354-8.
13. Coursaget P, Yvonnet B, Bourdil C, Buisson Y, Chotard J, N'Doye R, et al. Hepatitis B virus surface antigen reactivity in man due to a new variant of hepatitis B virus. Vaccine 1990;8:S15-7.
14. Echevarría JM. Variantes del virus de la hepatitis B. Su importancia epidemiológica y clínica. Virología 1993;1:131-41.
15. Valliammai T, Echevarría JM, León P, Tuset C, Harrison TJ. Amplification and sequence analysis of the precore and core region of the HBV genome from sera of Spanish patients with HBV2-like infections. J Med Virol 1995;46:375-9.
16. Feitelson M, Duan L-X, Horiike N, Clayton M. Hepatitis B X open reading frame deletion mutants isolated from atypical hepatitis B infections. J Hepatol 1991;13:S58-60.
17. Repp R, Keller C, Borkhardt A, Csecke A, Schaefer S, Gerlich WH, et al. Detection of a hepatitis B virus variant with a truncated X gene and enhancer II. Arch Virol 1992;125:299-304.
18. Challapalli M, Slosar M, Vasa R, Cunningham DG. Brief surface antigenemia in newborn infants vaccinated with hepatitis B vaccine. Pediatr Infect Dis J 1993;46:375-9.
19. Köksal N, Altinkaya N, Perk Y. Transient hepatitis B surface antigenemia after neonatal hepatitis B immunization. Acta Paediatr 1996;85:1501-2.
20. Kloster B, Kramer R, Eastlund T, Grossman B, Zarvan B. Hepatitis B surface antigenemia in blood donors following vaccination. Transfusion 1995;35:475-7.
21. Kear TM, Wright LS. Transient hepatitis B antigenemia in hemodialysis following hepatitis B vaccination. Ann J 1996;23:331.
22. Janzen L, Minuk GY, Fast M, Bernstein KN. Vaccine-induced hepatitis B surface antigen positivity in adult hemodialysis patients: Incidental and surveillance data. J Am Soc Nephrol 1996;7:1228-34.
23. Santana OE, Morillas C, Esparza N, Toledo A, Checa MD, Martín Sánchez AM. Antigenemia transitoria de superficie de la hepatitis B en pacientes en hemodiálisis. Rev Clin Esp 1999;199:198-201.
24. Stuyver L, Van Geyt C, De Gendt S, Van Reybroeck G, Zoulim F, Leroux-Roels G, et al. Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy. J Clin Microbiol 2000;38:702-7.
25. Hoofnagle JH, Seef LB, Bales ZB, Gerety RJ, Tabor E. Serologic responses in HB. En: Vyas GN, Cohen SN, Schmid R, editors. Viral hepatitis: A contemporary assessment of etiology, epidemiology, pathogenesis and prevention. Philadelphia: Franklin Institute Press, 1978; p. 193-201.
26. León P, López JA, Echevarría JM. Sensitivity of seven commercial assays in the detection of hepatitis B virus type 2-like infections. Eur J Clin Microbiol Infect Dis 1992;11:639-42.
27. Fiordalisi G, Primi D, Tanzi E, Magni E, Incarbone C, Zanetti A, et al. Hepatitis B virus C gene heterogeneity in a familial cluster of anti-HBc negative chronic carriers. J Med Virol 1994;42:109-14.
28. Tordjeman M, Fontan G, Rabillon V, Martin J, Trepo C, Hoffenbach A, et al. Characterization of minor and major antigenic regions within the hepatitis B virus nucleocapsid. J Med Virol 1993;41:221-9.
29. Echevarría JM, León P, Domingo C, López JA. Atypical hepatitis B virus in Spain? Lancet 1988;II:1315-6.